Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMPHENOL CORP /DE/APH · Entity 2846 | Director | May 22, 2026 | May 27, 2026 |
| LINDE PLCLIN · Entity 2835 | Director · Chairman & CEO | March 09, 2026 | March 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMPHENOL CORP /DE/
Report date May 22, 2026 · Filed May 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted StockSEC Table I · non-derivative | Direct | 1,552 |
Reported balance
After 2026-05-22 transaction · row 1
1 source rowRow 1 · 2026-05-22 · Grant · Acquired 1,552 · Balance 1,552 F1: Stock awards granted pursuant to the terms of the 2024 Restricted Stock Plan for Directors of Amphenol Corporation. |
| Class A Common StockSEC Table I · non-derivative | Direct | 548 |
Reported balance
Holding disclosure · report date 2026-05-22 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 548 |
Filing footnotes · ownership attribution and instrument terms
F1: Stock awards granted pursuant to the terms of the 2024 Restricted Stock Plan for Directors of Amphenol Corporation.
LINDE PLC
Report date March 09, 2026 · Filed March 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 109,161.191 |
Ending reported balance
After 2026-03-09 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2026-03-09 · Exercise / conversion · Acquired 19,892 · Balance 110,686.191 F1: Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2023. Row 2 · 2026-03-09 · Tax withholding · Disposed 9,218 · Balance 101,468.191 F2: Ordinary shares withheld from the payout to cover tax withholdings. Row 3 · 2026-03-09 · Exercise / conversion · Acquired 7,015 · Balance 108,483.191 F1: Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2023. Row 4 · 2026-03-09 · Tax withholding · Disposed 3,251 · Balance 105,232.191 F2: Ordinary shares withheld from the payout to cover tax withholdings. Row 5 · 2026-03-09 · Exercise / conversion · Acquired 7,015 · Balance 112,247.191 F3: Ordinary shares acquired pursuant to the payout of a restricted stock unit grant made on March 7, 2023. Row 6 · 2026-03-09 · Tax withholding · Disposed 3,086 · Balance 109,161.191 F2: Ordinary shares withheld from the payout to cover tax withholdings. |
| Performance Share Units (ROC)SEC Table II · derivative / convertible security | Direct | 19,892 |
Reported balance
After 2026-03-09 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-03-09 · Grant · Acquired 19,892 · Balance 19,892 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F5: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2023-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023. |
| Performance Share Units (ROC)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-03-09 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-03-09 · Exercise / conversion · Disposed 19,892 · Balance 0 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F5: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2023-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023. |
| Performance Share Units (RTSR)SEC Table II · derivative / convertible security | Direct | 7,015 |
Reported balance
After 2026-03-09 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-03-09 · Grant · Acquired 7,015 · Balance 7,015 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F6: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the relative total shareholder return ("RTSR") of Linde plc from 2023-2025 measured against RTSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023. |
| Performance Share Units (RTSR)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-03-09 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-03-09 · Exercise / conversion · Disposed 7,015 · Balance 0 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F6: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the relative total shareholder return ("RTSR") of Linde plc from 2023-2025 measured against RTSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 7,328 |
Reported balance
After 2026-03-09 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-03-09 · Grant · Acquired 7,328 · Balance 7,328 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F7: Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-03-09 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2026-03-09 · Exercise / conversion · Disposed 7,015 · Balance 0 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F10: Restricted Stock Units that vested in full and paid out on March 9, 2026 in Linde plc Ordinary Shares on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,364 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 6,364 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F8: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,405 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 6,405 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F9: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $483.62 · Expires 2036-03-09 | Direct | 59,746 |
Reported balance
After 2026-03-09 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2026-03-09 · Grant · Acquired 59,746 · Balance 59,746 F11: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $468.77 · Expires 2035-03-07 | Direct | 44,696 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 44,696 F12: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $465.29 · Expires 2034-03-07 | Direct | 41,530 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 41,530 F13: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $354.14 · Expires 2033-03-07 | Direct | 46,365 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 46,365 F14: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $270.99 · Expires 2032-03-07 | Direct | 54,920 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · Balance 54,920 F15: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $253.68 · Expires 2031-03-08 | Direct | 40,995 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · Balance 40,995 F16: This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $173.13 · Expires 2030-03-09 | Direct | 37,565 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · Balance 37,565 F17: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $176.63 · Expires 2029-03-20 | Direct | 15,470 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · Balance 15,470 F18: This option vests over three years in three consecutive equal annual installments beginning March 20, 2020. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 546.348 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · Balance 546.348 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F19: Deferred Stock Units acquired under the Linde Compensation Deferral Plan that will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Deferral Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2023.
F2: Ordinary shares withheld from the payout to cover tax withholdings.
F3: Ordinary shares acquired pursuant to the payout of a restricted stock unit grant made on March 7, 2023.
F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis.
F5: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2023-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023.
F6: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the relative total shareholder return ("RTSR") of Linde plc from 2023-2025 measured against RTSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023.
F7: Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis.
F8: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
F9: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
F10: Restricted Stock Units that vested in full and paid out on March 9, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
F11: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027.
F12: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
F13: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
F14: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
F15: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
F16: This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
F17: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
F18: This option vests over three years in three consecutive equal annual installments beginning March 20, 2020.
F19: Deferred Stock Units acquired under the Linde Compensation Deferral Plan that will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Deferral Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 20, 2019 Filed Mar 22, 2019 21:38 UTC | LINDE PLC LIN · Entity 2835 | GrantRistricted Stock Units · Derivative | 3,590 | $0.00 | $0.00 |
DisclosureSEC source: 0001707925-19-000026 · edgar.xml · derivative · entry 2 Lamba Sanjiv · CIK 0001757274 · Head of APAC Gases 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,590 Underlying: Ordinary Shares · 3,590 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shares on a one-for-one basis. F1 · derivative.exercise_date: Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shares on a one-for-one basis. F1 · derivative.expiration_date: Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shares on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.